Pravin Dugel
Chief Executive Officer bij OCULAR THERAPEUTIX, INC.
Vermogen: 8 M $ op 31-03-2024
Profiel
Pravin U.
Dugel is the founder of Spectra Eye Institute.
He currently holds multiple positions, including Chairman, President & Chief Executive Officer at Ocular Therapeutix, Inc. since 2024, Director at ORBIS International, Inc. since 2017, Director at the American Society of Retinal Specialists, Director at EURETINA –.
Europäische Gesellschaft für Netzhautspezialisten, Independent Non-Executive Director at Oculis Holding AG since 2020, and Professor at the University of Southern California.
Dr. Dugel has previously worked as Chairman-Retina Subspecialty Day Board at the American Academy of Ophthalmology, Inc., Director at Aerpio Therapeutics, Inc., President & Director at IVERIC bio, Inc. from 2020 to 2023, Independent Director at Aerpio Pharmaceuticals, Inc. from 2017 to 2021, Managing Partner at Retinal Consultants of Arizona Ltd.
from 1994 to 2019, Managing Partner at Retinal Research Institute LLC, Professor at Keck School of Medicine of USC, and Clinical Professor at USC Roski Eye Institute.
He has an undergraduate degree from The Trustees of Columbia University in The City of New York and a graduate degree from David Geffen School of Medicine.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
OCULAR THERAPEUTIX INC
0.58% | 22-02-2024 | 854 979 ( 0.58% ) | 8 M $ | 31-03-2024 |
Actieve functies van Pravin Dugel
Bedrijven | Functie | Begin |
---|---|---|
OCULIS HOLDING AG | Director/Board Member | 01-04-2020 |
OCULAR THERAPEUTIX, INC. | Chief Executive Officer | 15-04-2024 |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | - |
EURETINA – Europäische Gesellschaft für Netzhautspezialisten | Director/Board Member | - |
American Society of Retinal Specialists | Director/Board Member | - |
ORBIS International, Inc.
ORBIS International, Inc. Hospital/Nursing ManagementHealth Services ORBIS International, Inc. prevents and treats blindness by providing eye care to transform lives. It offers tools, training and technology necessary for local partners to develop eye care services. The company was founded in 1982 by David Paton and is headquartered in New York, NY. | Director/Board Member | 27-09-2017 |
Eerdere bekende functies van Pravin Dugel
Bedrijven | Functie | Einde |
---|---|---|
IVERIC BIO, INC. | President | 11-07-2023 |
AERPIO PHARMACEUTICALS | Director/Board Member | 26-08-2021 |
Retinal Consultants of Arizona Ltd.
Retinal Consultants of Arizona Ltd. Hospital/Nursing ManagementHealth Services Retinal Consultants of Arizona Ltd. operates as an ophthalmology clinic. The private company is based in Phoenix, AZ. | Corporate Officer/Principal | 01-01-2019 |
░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░ | - |
░░░ ░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Opleiding van Pravin Dugel
The Trustees of Columbia University in The City of New York | Undergraduate Degree |
David Geffen School of Medicine | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
OCULAR THERAPEUTIX, INC. | Health Technology |
OCULIS HOLDING AG | Health Technology |
Bedrijven in privébezit | 11 |
---|---|
Aerpio Therapeutics, Inc.
Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. | Health Technology |
ORBIS International, Inc.
ORBIS International, Inc. Hospital/Nursing ManagementHealth Services ORBIS International, Inc. prevents and treats blindness by providing eye care to transform lives. It offers tools, training and technology necessary for local partners to develop eye care services. The company was founded in 1982 by David Paton and is headquartered in New York, NY. | Health Services |
American Academy of Ophthalmology, Inc.
American Academy of Ophthalmology, Inc. Miscellaneous Commercial ServicesCommercial Services American Academy of Ophthalmology, Inc. is the world's largest association of eye physicians and surgeons. The non-profit company is based in San Francisco, CA, and has subsidiaries in the United States. The company advocates for patients and the public and set standards for ophthalmic education. The organization provides information about managing a practice, clinical pearls, and how to thrive in residency for young ophthalmologists. The company also offers an Outstanding Humanitarian Service Award and have committees that are essential to the establishment and implementation of the organization's mission and strategic goals. The Academy's website, EyeSmart, provides information on eye diseases, treatments, news, and tips for lifelong eye health. The company also has a faculty development program for their annual meeting and offer a program called Eyecelerator that advances eye care innovation by connecting creative entrepreneurs with mission-driven investors and access to markets. | Commercial Services |
IVERIC bio, Inc.
IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
American Society of Retinal Specialists | |
Retinal Consultants of Arizona Ltd.
Retinal Consultants of Arizona Ltd. Hospital/Nursing ManagementHealth Services Retinal Consultants of Arizona Ltd. operates as an ophthalmology clinic. The private company is based in Phoenix, AZ. | Health Services |
Aerpio Pharmaceuticals, Inc.
Aerpio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Pharmaceuticals Inc. is a biopharmaceutical company, which engages in the research and development of treatments for ocular diseases. The firm's product candidate is AKB-9778, a small molecule activator of the Tie2 pathway, which completed the Phase 2a clinical trial for the treatment of diabetic retinopathy. It also develops ARP-1536, a humanized monoclonal antibody that is in preclinical development stage for the treatment of diabetic vascular complications; and AKB-4924, a selective stabilizer of hypoxia-inducible factor-1 alpha, which has completed a single ascending dose clinical trial for the treatment of inflammatory bowel disease. The company was founded by Joseph H. Garder on November 16, 2007 and is headquartered in Cincinnati, OH. | Health Technology |
EURETINA – Europäische Gesellschaft für Netzhautspezialisten | |
Spectra Eye Institute
Spectra Eye Institute Medical/Nursing ServicesHealth Services Spectra Eye Institute operates an eye care center. The private company is based in Sun City. The American company was founded by Pravin U. Dugel. | Health Services |
Usc Roski Eye Institute
Usc Roski Eye Institute Medical/Nursing ServicesHealth Services USC Roski Eye Institute operates eye care clinics. The private company is based in Arcadia. | Health Services |
Retinal Research Institute LLC |